EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis

Bethan L Thomas, Trinidad Montero-Melendez, Silvia Oggero, Magdalena K Kaneva, David Chambers, Andreia L Pinto, Alessandra Nerviani, Davide Lucchesi iD, Shani Austin-Williams, Mohammed T Hussain, Costantino Pitzalis iD, Benjamin Allen und 4 weitere

Arthritis & Rheumatology · 2024-12 · 76 (12) · 1705-1718

DOI: 10.1002/art.42958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 16.08.2024. Verfasst von Bethan L Thomas und 15 weiteren Autor:innen. Beteiligte Einrichtung: Queen Mary University of London, London, United Kingdom. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neutrophils, MicroRNAs, Regeneration. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Versus Arthritis Senior Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to establish the potential therapeutic profile of neutrophil‐derived extracellular vesicles (EVs) in experimental inflammatory arthritis and associate pharmacological activity with specific EV components, focusing on microRNAs.

Methods

Neutrophil EVs were administered intra‐articularly through a prophylactic or therapeutic protocol to male C57BL/6 mice undergoing serum‐transfer–induced inflammatory arthritis. Transcriptomic analysis of knees was performed on joints following EV administration, naive and arthritic mice (untreated; n = 4/group) and EV‐treated diseased mice (intra‐articular administration) with contralateral (vehicle‐treated; n = 8/group). Comparison of healthy donor and patients with rheumatoid arthritis (RA) neutrophil EVs was performed.

Results

EVs afforded cartilage protection with an increase in collagen‐II and reduced collagen‐X expression within the joint. To gain mechanistic insights, RNA sequencing of the arthritic joints was conducted. A total of 5,231 genes were differentially expressed ( P < 0.05), with 257 unique to EV treatment. EVs affected key regenerative pathways involved in joint development, including Wnt and Notch signaling. This wealth of genomic alteration prompted to identify microRNAs in EVs, 10 of which are associated with RA. As a proof of concept, we focused on miR‐455‐3p, which was detected in both healthy donor and RA EVs. EV addition to chondrocyte cultures elevated miR‐455‐3p and exerted anticatabolic effects upon interleukin‐1β stimulation; these effects were blocked by actinomycin or miR‐455‐3p antagomir.

Conclusion

Neutrophils from patients with RA yielded EVs with composition, efficacy, and miR‐455‐3p content similar to those of healthy volunteers, suggesting that neutrophil EVs could be developed as an autologous treatment to protect and repair joint tissue of patients affected by inflammatory arthritides. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesNeutrophilsMicroRNAsRegenerationArthritis, ExperimentalArthritis, RheumatoidMice, Inbred C57BLCartilage, ArticularAnimalsMiceMaleHumansInjections, Intra-Articular

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Queen Mary University of London, London, United Kingdom.
  • Queen Mary University of London and Kings College London, Guys' Campus, London, United Kingdom.
  • Kings College London, Guys' Campus, London, United Kingdom.
  • Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
  • Queen Mary University of London, Barts Health NHS Trust, and National Institute for Health and Care Research Barts Biomedical Research Centre, London, United Kingdom.

ORCID-Profile: Davide Lucchesi, Costantino Pitzalis, Lucy V Norling

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Versus Arthritis Senior Research Fellowship
  • Medical Research Council Regenerative Medicine Panel
  • National Institute for Health and Care Research Barts Biomedical Research Centres

Zitieren

APA

Thomas, B. L., Montero-Melendez, T., Oggero, S., Kaneva, M. K., Chambers, D., Pinto, A. L., Nerviani, A., Lucchesi, D., Austin-Williams, S., Hussain, M. T., Pitzalis, C., Allen, B., Malcangio, M., Dell'Accio, F., Norling, L. V., & Perretti, M. (2024). Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis. Arthritis & Rheumatology, 76(12), 1705-1718. https://doi.org/10.1002/art.42958

Vancouver

Thomas BL, Montero-Melendez T, Oggero S, Kaneva MK, Chambers D, Pinto AL, et al. Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis. Arthritis & Rheumatology. 2024;76(12):1705-1718. doi:10.1002/art.42958

BibTeX
@article{Thomas2024,
  author = {Thomas, Bethan L and Montero-Melendez, Trinidad and Oggero, Silvia and Kaneva, Magdalena K and Chambers, David and Pinto, Andreia L and Nerviani, Alessandra and Lucchesi, Davide and Austin-Williams, Shani and Hussain, Mohammed T and Pitzalis, Costantino and Allen, Benjamin and Malcangio, Marzia and Dell'Accio, Francesco and Norling, Lucy V and Perretti, Mauro},
  title = {Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  volume = {76},
  number = {12},
  pages = {1705--1718},
  doi = {10.1002/art.42958}
}
Kostenlos starten →